Pharmabiz15m
Robles BioCeutics collaborates with BioCentrium to explore the molecular mechanisms behind Glowselle stem cell activator
Robles BioCeutics LLC, a regenerative dermatology company, announced a new collaboration with BioCentrium aimed at advancing research into the molecular mechanisms behind its patent-pending Glowselle ...
Pharmabiz1h
Leucine Rich Bio unveils #HappyGutMission campaign, survey indicates 29.7% individuals report frequent antibiotic use
Leucine Rich Bio, now unveils its #HappyGutMission campaign an initiative designed to educate people on the critical role of gut health. This campaign has brought gut health to the forefront, offering ...
Pharmabiz1h
US FDA advisory panel votes in favour of IceCure's ProSense cryoablation benefit-risk profile in early-stage low risk breast cancer
US FDA advisory panel votes in favour of IceCure's ProSense cryoablation benefit-risk profile in early-stage low risk breast cancer: Caesarea, Israel Monday, November 11, 2024, 15 ...
Pharmabiz2h
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours: Redmond, Washington Monday, November 11, 2024, 14:00 Hrs [IST] SystImmune, Inc (SystImmune), a ...
Pharmabiz2h
Quantiphi and DDReg partner to transform regulatory reporting in life sciences through AI
Quantiphi, a global AI-first digital engineering company, and DDReg, a global leader in regulatory expertise, has inked a partnership that will address regulatory challenges that pharmaceutical ...
Pharmabiz44m
EMA’s veterinary committee issues first certificate for vaccine platform technology master file
EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...
Pharmabiz1h
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Johnson & Johnson announced the submission of regulatory applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval of a new indication for Darzalex ...
Pharmabiz8h
Ayush and herbal products exports grow over 10 per cent in H1 FY25
Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as ...
Pharmabiz3h
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...
Pharmabiz4h
Divis Laboratories net profit grew 47% in Q2FY25
Our Bureau, New Delhi Monday, November 11, 2024, 11:15 Hrs [IST] Hyderabad-based Divis Laboratories has registered a growth of 46 ...
Pharmabiz4h
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...
Pharmabiz4h
Akums Drugs and Pharmaceuticals net profit doubles in Q2FY25
Akums Drugs and Pharmaceuticals has witnessed its net profit for the second quarter of the current fiscal year doubling to Rs. 66.65 crore from Rs. 32.69 crore registered during the same quarter last ...